Indian pharmaceutical companies are set to beat 2018-19’s (FY19’s) exports this financial year, despite the strict regulatory action by the US Food and Drug Administration (USFDA), its largest market. The data from the Pharmaceutical Exports Promotion Council (Pharmexcil) shows exports clocked 11.5 per cent growth during the April to December period of 2019-20 (FY20).
The December quarter was particularly good for Indian pharma, clocking 14.6 per cent growth. It was a sharp improvement from the 8.69 per cent growth during the second quarter of the financial year. The March ...
TO READ THE FULL STORY, SUBSCRIBE NOW NOW AT JUST Rs
Key stories on business-standard.com are available to premium subscribers only.
Already a premium subscriber? LOGIN NOW
First Published: Fri, February 07 2020. 22:39 IST
